Omega Fund Management as of June 30, 2023
Portfolio Holdings for Omega Fund Management
Omega Fund Management holds 12 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Replimune Group Common Stock (REPL) | 39.0 | $70M | 3.0M | 23.22 | |
| Nuvation Bio Common Stock Class A (NUVB) | 15.2 | $27M | 15M | 1.80 | |
| Alpine Immune Sciences Common Stock | 11.7 | $21M | 2.0M | 10.28 | |
| Morphic Holding Common Stock (MORF) | 10.0 | $18M | 310k | 57.33 | |
| Ikena Oncology Common Stock (IKNA) | 8.3 | $15M | 2.2M | 6.56 | |
| Theseus Pharmaceuticals Common Stock | 3.7 | $6.6M | 712k | 9.33 | |
| Kronos Bio Common Stock (KRON) | 3.7 | $6.6M | 3.8M | 1.72 | |
| Sana Biotechnology Common Stock (SANA) | 2.8 | $5.0M | 844k | 5.96 | |
| Spruce Biosciences Common Stock (SPRB) | 2.6 | $4.6M | 2.2M | 2.15 | |
| Immunic Common Stock (IMUX) | 2.5 | $4.5M | 1.8M | 2.51 | |
| Syros Pharmaceuticals Common Stock (SYRS) | 0.4 | $792k | 251k | 3.15 | |
| Senti Biosciences Common Stock (SNTI) | 0.1 | $123k | 196k | 0.63 |
